Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury

Olga N. Kokiko, Alexander K. Murashov, Michael R. Hoane

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Hormonal differences between males and females have surfaced as a crucial component in the search for effective treatments after experimental models of traumatic brain injury (TBI). Recent findings have shown that selective estrogen receptor modulators (SERMs) may have therapeutic benefit. The present study examined the effects of raloxifene, a SERM, on functional recovery after bilateral cortical contusion injury (bCCI) or sham procedure. Male rats received injections of raloxifene (3.0 mg/kg, i.p.) or vehicle (1.0 ml/kg, i.p.) 15 min, 24, 48, 72, and 96 h after bCCI or sham procedure. Rats were tested on both sensorimotor (bilateral tactile removal and locomotor placing tests) and cognitive tests (reference and working memory in the Morris water maze). Raloxifene-treated animals showed a significant reduction in the initial magnitude of the deficit and facilitated the rate of recovery for the bilateral tactile removal test, compared to vehicle-treated animals. The raloxifene-treated animals also showed a significant improvement in the acquisition of working memory compared to vehicle-treated animals. However, raloxifene did not significantly improve the acquisition of reference memory or locomotor placing ability. Raloxifene treatment also did not result in a significant reduction in the size of the lesion cavity. Thus, the task-dependent improvements seen following raloxifene treatment do not appear to be the result of cortical neuroprotection. However, these results suggest that raloxifene improves functional outcome following bCCI and may present an interesting avenue for future research.

Original languageEnglish (US)
Pages (from-to)233-240
Number of pages8
JournalBehavioural Brain Research
Volume170
Issue number2
DOIs
StatePublished - Jun 30 2006
Externally publishedYes

Fingerprint

Memory Disorders
Short-Term Memory
Selective Estrogen Receptor Modulators
Touch
Wounds and Injuries
Aptitude
Raloxifene Hydrochloride
Traumatic Brain Injury
Therapeutics
Theoretical Models
Injections
Water

Keywords

  • Neuroprotection
  • Rat
  • Recovery of function
  • SERM
  • Traumatic brain injury

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury. / Kokiko, Olga N.; Murashov, Alexander K.; Hoane, Michael R.

In: Behavioural Brain Research, Vol. 170, No. 2, 30.06.2006, p. 233-240.

Research output: Contribution to journalArticle

@article{5ab47058b72d4d529894bafa7e2c70bc,
title = "Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury",
abstract = "Hormonal differences between males and females have surfaced as a crucial component in the search for effective treatments after experimental models of traumatic brain injury (TBI). Recent findings have shown that selective estrogen receptor modulators (SERMs) may have therapeutic benefit. The present study examined the effects of raloxifene, a SERM, on functional recovery after bilateral cortical contusion injury (bCCI) or sham procedure. Male rats received injections of raloxifene (3.0 mg/kg, i.p.) or vehicle (1.0 ml/kg, i.p.) 15 min, 24, 48, 72, and 96 h after bCCI or sham procedure. Rats were tested on both sensorimotor (bilateral tactile removal and locomotor placing tests) and cognitive tests (reference and working memory in the Morris water maze). Raloxifene-treated animals showed a significant reduction in the initial magnitude of the deficit and facilitated the rate of recovery for the bilateral tactile removal test, compared to vehicle-treated animals. The raloxifene-treated animals also showed a significant improvement in the acquisition of working memory compared to vehicle-treated animals. However, raloxifene did not significantly improve the acquisition of reference memory or locomotor placing ability. Raloxifene treatment also did not result in a significant reduction in the size of the lesion cavity. Thus, the task-dependent improvements seen following raloxifene treatment do not appear to be the result of cortical neuroprotection. However, these results suggest that raloxifene improves functional outcome following bCCI and may present an interesting avenue for future research.",
keywords = "Neuroprotection, Rat, Recovery of function, SERM, Traumatic brain injury",
author = "Kokiko, {Olga N.} and Murashov, {Alexander K.} and Hoane, {Michael R.}",
year = "2006",
month = "6",
day = "30",
doi = "10.1016/j.bbr.2006.02.026",
language = "English (US)",
volume = "170",
pages = "233--240",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury

AU - Kokiko, Olga N.

AU - Murashov, Alexander K.

AU - Hoane, Michael R.

PY - 2006/6/30

Y1 - 2006/6/30

N2 - Hormonal differences between males and females have surfaced as a crucial component in the search for effective treatments after experimental models of traumatic brain injury (TBI). Recent findings have shown that selective estrogen receptor modulators (SERMs) may have therapeutic benefit. The present study examined the effects of raloxifene, a SERM, on functional recovery after bilateral cortical contusion injury (bCCI) or sham procedure. Male rats received injections of raloxifene (3.0 mg/kg, i.p.) or vehicle (1.0 ml/kg, i.p.) 15 min, 24, 48, 72, and 96 h after bCCI or sham procedure. Rats were tested on both sensorimotor (bilateral tactile removal and locomotor placing tests) and cognitive tests (reference and working memory in the Morris water maze). Raloxifene-treated animals showed a significant reduction in the initial magnitude of the deficit and facilitated the rate of recovery for the bilateral tactile removal test, compared to vehicle-treated animals. The raloxifene-treated animals also showed a significant improvement in the acquisition of working memory compared to vehicle-treated animals. However, raloxifene did not significantly improve the acquisition of reference memory or locomotor placing ability. Raloxifene treatment also did not result in a significant reduction in the size of the lesion cavity. Thus, the task-dependent improvements seen following raloxifene treatment do not appear to be the result of cortical neuroprotection. However, these results suggest that raloxifene improves functional outcome following bCCI and may present an interesting avenue for future research.

AB - Hormonal differences between males and females have surfaced as a crucial component in the search for effective treatments after experimental models of traumatic brain injury (TBI). Recent findings have shown that selective estrogen receptor modulators (SERMs) may have therapeutic benefit. The present study examined the effects of raloxifene, a SERM, on functional recovery after bilateral cortical contusion injury (bCCI) or sham procedure. Male rats received injections of raloxifene (3.0 mg/kg, i.p.) or vehicle (1.0 ml/kg, i.p.) 15 min, 24, 48, 72, and 96 h after bCCI or sham procedure. Rats were tested on both sensorimotor (bilateral tactile removal and locomotor placing tests) and cognitive tests (reference and working memory in the Morris water maze). Raloxifene-treated animals showed a significant reduction in the initial magnitude of the deficit and facilitated the rate of recovery for the bilateral tactile removal test, compared to vehicle-treated animals. The raloxifene-treated animals also showed a significant improvement in the acquisition of working memory compared to vehicle-treated animals. However, raloxifene did not significantly improve the acquisition of reference memory or locomotor placing ability. Raloxifene treatment also did not result in a significant reduction in the size of the lesion cavity. Thus, the task-dependent improvements seen following raloxifene treatment do not appear to be the result of cortical neuroprotection. However, these results suggest that raloxifene improves functional outcome following bCCI and may present an interesting avenue for future research.

KW - Neuroprotection

KW - Rat

KW - Recovery of function

KW - SERM

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=33646514847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646514847&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2006.02.026

DO - 10.1016/j.bbr.2006.02.026

M3 - Article

C2 - 16580743

AN - SCOPUS:33646514847

VL - 170

SP - 233

EP - 240

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 2

ER -